MENU
IFRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

InflaRx (IFRX) Earnings Date & Reports

InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

IFRX is expected to report earnings to rise 88.89% to -17 cents per share on May 07

InflaRx IFRX Stock Earnings Reports
Q1'25
Est.
$-0.17
Q4'24
Beat
by $0.16
Q3'24
Missed
by $0.05
Q2'24
Missed
by $0.04
Q1'24
Beat
by $0.02
The last earnings report on March 20 showed earnings per share of -9 cents, beating the estimate of -25 cents. With 172.37K shares outstanding, the current market capitalization sits at 71.50M.
View a ticker or compare two or three
IFRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of biopharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
Winzerlaer Strasse 2
Phone
+49 3641508180
Employees
66
Web
https://www.inflarx.de